True Wealth Design’s Pacira BioSciences PCRX Stock Holding History

True Wealth Design’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.65K	Hold	341	–	–	﹤0.01%	1115
2026 Q1	$7.71K	Hold	341	–	–	﹤0.01%	1062
2025 Q4	$8.83K	Hold	341	–	–	﹤0.01%	910
2025 Q3	$8.79K	Hold	341	–	–	﹤0.01%	883
2025 Q2	$8.15K	Hold	341	–	–	﹤0.01%	647
2025 Q1	$8.47K	Hold	341	–	–	﹤0.01%	521
2024 Q4	$6.42K	Buy	341 +78	+30%	+$1.37K	﹤0.01%	491
2024 Q3	$3.96K	Buy	+263	New	+$4.5K	﹤0.01%	617

Other funds holding PCRX

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Assenagon Asset Management

Assenagon Asset Management Senningerberg, Luxembourg $77B AUM 50.57% 1-Year Est. Return

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

Milestone Asset Management Pittsburgh, Pennsylvania $635M AUM 22.1% 1-Year Est. Return

Empirical Wealth Management Seattle, Washington $6.82B AUM 30.02% 1-Year Est. Return

Wealth Enhancement Advisory Services

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.6B AUM 29.42% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return

1620 Investment Advisors Plymouth, Massachusetts $161M AUM 30.15% 1-Year Est. Return

Adirondack Trust Company Saratoga Springs, New York $336M AUM 29.2% 1-Year Est. Return